doi: 10.1016/j.regpep.2004.06.020 50 MentleinRGallwitzBSchmidtWE
Identify which entity provides the technology platform, which provides clinical evaluation, and which dispenses medications
Unlike classical T1D with almost only hyperglycemia, T2D is just one component of MDS, and is often accompanied by other components of MDS, such as overweight/obesity (preobesity might be a more appropriate term instead of overweight since obesity is not determined only by weight), metabolic dysfunction associated steatotic liver disease (MASLD), dyslipidemia
Unlike many compounds that are used once, glutathione can be regenerated and reused many times
While earlier GLP-1 drugs have decades of data behind them, newer high-potency agonists and multi-agonist combinations will require extended monitoring as their use expands